Submissions for the 2026 Paul Wender Best Paper in The Journal of Clinical Psychiatry are now closed.
The American Society of Clinical Psychopharmacology (ASCP) presents the Paul Wender Best Paper in The Journal of Clinical Psychiatry Award to a recipient who has been published in the past year (January 2025 to present date) for The Journal of Clinical Psychiatry.
Known as the “Dean of ADHD” by his colleagues, Paul H. Wender, MD, was a pioneer in identifying and treating attention deficit hyperactivity disorder. A researcher and clinician who treated patients with ADHD for many years, he offered insights into the progression of ADHD, as well as dietary, drug, and psychological treatments. He was the author of the classic handbook on the subject, ADHD: Attention-Deficit Hyperactivity Disorder in Children and Adults.
Wender was involved in the study of ADHD for over thirty years and wrote the first monograph on the disorder in 1971 (Minimal Brain Dysfunction in Children). In this monograph, he advanced the hypotheses that the disorder was genetic in origin and was mediated by decreased activity in dopaminergic systems in the brain. Because he found education of the parents of ADHD children played a substantial role in treatment, he described the symptoms, the causes, and the management of children with ADHD in a book published in 1974, The Hyperactive Child. The 4th edition, ADHD in Children and Adults, was published in 2000 and contains information for ADHD adults about how accurate diagnosis can be made and how ADHD in adults is best treated. He and his colleagues discovered that ADHD in adults was a recognizable disorder. They initiated studies of ADHD in adults beginning in 1976 and have conducted extensive research in this area since that time. He wrote the first monograph on ADHD in adults (Attention Deficit Hyperactivity Disorder in Adults) in 1995.
The award consists of a $1,000 stipend and a plaque to be given during the 2026 ASCP Annual Meeting (formerly NCDEU) on May 26-29, 2026 in Miami, FL. The Award Winner must attend the 2026 ASCP Annual Meeting.
The ASCP Award Committee will review the papers submitted to The Journal of Clinical Psychiatry for the 2025 year. Papers must be original reports or meta-analysis on patient relevant research relevant to clinical psychopharmacology. The top five downloaded papers from 2025 will also be included in the nomination.
Submission Deadline: January 28, 2026
Congratulations to the 2025 Paul Wender Best Paper in The Journal of Clinical Psychiatry Award Winner, Dr. Margaret Sibley!
Paper: Characteristics and predictors of fluctuating attention-deficit/hyperactivity disorder in the Multimodal Treatment of ADHD (MTA) study.
Dr. Margaret Sibley
Professor of Psychiatry and Behavioral Sciences at the University of Washington School of Medicine and a clinical psychologist at Seattle Children’s Hospital
Dr. Margaret Sibley is a Professor of Psychiatry and Behavioral Sciences at the University of Washington School of Medicine and a clinical psychologist at Seattle Children’s Hospital. She has authored over 120 scholarly publications on ADHD in adolescence and adulthood with research funded by the National Institute of Mental Health and the Institute of Education Sciences. She is Secretary of the American Professional Society for ADHD and Related Disorders (APSARD), a Professional Advisory Board Member for Children and Adults with Attention Deficit Hyperactivity Disorder (CHADD), and an Associate Editor of the Journal of Attention Disorders. She is the author of Parent-Teen Therapy for Executive Function Deficits and ADHD: Building Skills and Motivation published by Guilford Press in 2017.
Paul Wender Best Paper in The Journal of Clinical Psychiatry Awardees
| Year | Awardee | Affiliation | Paper Title |
| 2026 | Mary Hobart, Ph.D. | Otsuka Pharmaceutical Development and Commercialization, Inc. | Brexpiprazole in Combination With Sertraline and as Monotherapy in Posttramatic Stress Disorder: A Full-Factorial Randomized Clinical Trial |
| 2025 | Margaret Sibley, Ph.D. | Seattle Children‘s Hospital and University of Washington School of Medicine | Characteristics and Predictors of Fluctuating Attention-Deficit/Hyperactivity Disorder in the Multimodal Treatment of ADHD (MTA) Study |
| 2024 | Michel Sabè, M.D. | Clinical Psychiatrist, Head of Unit Geneva University Hospitals | Comparative Effects of 11 Antipsychotics on Weight Gain and Metabolic Function in Patients With Acute Schizophrenia: A Dose-Response Meta-Analysis |
| 2023 | Cynthia Calkin, M.D. | Dalhousie University | Treating Insulin Resistance with Metformin as a Strategy to Improve Clinical Outcomes in Treatment-Resistant Bipolar Depression (the TRIO-BD Study): A Randomized, Quadruple-Masked, Placebo-Controlled Clinical Trial |
| 2022 | Brandon Nitcher, Ph.D. | U.S. Special Operations Command | Prevalence, Correlates, and Treatment of Suicidal Behavior in US Military Veterans: Results From the 2019–2020 National Health and Resilience in Veterans Study |
| 2020/2021 | Maurizio Fava, M.D. | Harvard Medical School – Slater Family Professor and Associate Dean of Clinical and Translational Research | A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of Adjunctive Pimavanserin in Patients With Major Depressive Disorder and an Inadequate Response to Therapy (CLARITY) |
| 2019 | Randi Schuster, Ph.D. | Massachusetts General Hospital | One Month of Cannabis Abstinence in Adolescents and Young Adults Is Associated With Improved Memory |
| 2018 | Philip Gerretsen, FRCPC, M.D. | Centre for Addiction and Mental Health | Anasognosia is an Independent Predictor of Conversion from MCI to AD and is Associated with Reduced Brain Metabolis |
| 2017 | Emil Coccaro, M.D. | Prtizker School of Medicine | Toxoplasma gondii Infection: Relationships With |
| 2016 | Lee Baer, Ph.D. | Massachusetts General Hospital | Prevalence and Impact of Obsessive-Compulsive Symptoms in Depression: A STAR*D Report |
| 2015 | Roy Chengappa, M.D. | University of Pittsburgh School of Medicine | Smoking Cessation in Bipolar Disorder: A Randomized, Double-Blind, Placebo-Controlled Study |
| 2014 | Sophie Grigoriadis, M.D. | Sunnybrook Health Sciences Centre | Antidepressant Exposure During Pregnancy and Congenital Malformations: Is There an Association? A Systematic Review and Meta-Analysis of the Best Evidence |